Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis

Cancer

Volumn 106, Issue 1, 2006, Pages 28-34

  Ben David, Merav A ^a   Kleer, Celina G ^a   Paramagul, Chintana ^a   Griffith, Kent A ^a   Pierce, Lori J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast carcinoma; Breast conservation; Lobular carcinoma in situ (LCIS); Local control; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST CONSERVING TREATMENT; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CARCINOMA IN SITU; FEMALE; HORMONAL THERAPY; HUMAN; INVASIVE CARCINOMA; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MATCHED-PAIR ANALYSIS; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 29844445495     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21555     Document Type: Article

References (31)

1. Foote FW, Stewart FE. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17:491-505.
2. Wheeler JE, Enterline HT, Roseman JM, et al. Lobular carcinoma in situ of the breast: long-term follow-up. Cancer. 1974;34:554-563.
3. Haagensen CD, Lane N, Lattes R, et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737-769.
4. Rosen PP, Kosloff C, Lieberman PH, et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2:225-251.
5. Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002;75:259-268.
6. Levi F, Te V-C, Randimbison L, La Vecchia C. Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer. 1997;33:903-906.
7. Simon MS, Lemanne D, Schwartz AG, Martino S, Swanson GM. Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975-1988). Cancer. 1993;71:769-774.
8. Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561-2569.
9. Salvadori B, Bartoli C, Zurrida S, et al. Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer. 1991;27:35-37.
10. Andersen JA. Lobular carcinoma in situ of the breast: an approach to rational treatment. Cancer. 1977;39:2597-2602.
11. Page DL, Kidd TE Jr., Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-1239.
12. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia: long-term risk of breast cancer and relation to other factors. Cancer. 1996;78:1024-1034.
13. Schnitt SJ, Guidi AJ. Pathology of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:541-584.
14. Berg JW, Hutter RV. Breast cancer. Cancer. 1995;75:257.
15. Shelley Hwang E, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100:2562-2572.
16. Maluf H, Koerner F. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion. Int J Surg Pathol. 2001;9:127-131.
17. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol. 2001;54:91-97.
18. American College of Radiology. BI-RADS. Breast imaging reporting and data system atlas. Reston, VA: American College of Radiology, 2003.
19. Pierce LJ, Strawderman MH, Douglas KR, Lichter AS. Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: the University of Michigan experience. Int J Radiat Oncol Biol Phys. 1997;1;39:921-928.
20. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer, 1997.
21. Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer. 2001;91:1862-1869.
22. Moran M, Haffty BG. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 1998;40:353-358.
23. Abner AL, Connolly JL, Recht A, et al. The relationship between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer. 2000;88:1072-1077.
24. Agresti A. Categorical data analysis. New York: John Wiley & Sons, 1990.
25. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;15;20:4141-4149.
26. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;2;351:971-977.
27. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;2;351:963-970.
28. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;12;353:1993-2000.
29. Fisher B, Costantino JP, Lawrence D, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
30. McDivitt RW, Mutter RV, Foote FW Jr., Stewart FW. In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA. 1967;10;201:82-86.
31. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100:238-244.